A study of over 20,000 women with breast cancer identified care beyond guidelines through high rates of risk-reducing surgery, specifically bilateral mastectomy, in women with GPVs in breast cancer-associated genes other than BRCA1/2 (95% CI, 37.7−48.5%) [18]. This evidence concerns the gene BRCA1 and breast cancer.